Brief: Sprint Bioscience Q1 Operating Profit Rises To SEK 7.3 Million
May 16 (Reuters) - SPRINT BIOSCIENCE AB SPRINT.ST :
* Q1 REVENUE SEK 19.9 MILLION VERSUS SEK 12.1 MILLION YEAR
AGO
* Q1 OPERATING PROFIT SEK 7.3 MILLION VERSUS SEK 1.1 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkrw7nzY
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln